Yingfeng Shi

1.6k total citations
45 papers, 1.3k citations indexed

About

Yingfeng Shi is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Yingfeng Shi has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 17 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Yingfeng Shi's work include Dialysis and Renal Disease Management (17 papers), Gout, Hyperuricemia, Uric Acid (12 papers) and Pancreatitis Pathology and Treatment (7 papers). Yingfeng Shi is often cited by papers focused on Dialysis and Renal Disease Management (17 papers), Gout, Hyperuricemia, Uric Acid (12 papers) and Pancreatitis Pathology and Treatment (7 papers). Yingfeng Shi collaborates with scholars based in China and United States. Yingfeng Shi's co-authors include Shougang Zhuang, Na Liu, Liuqing Xu, Andong Qiu, Xiaoyan Ma, Min Tao, Yan Hu, Na Liu, Hui Chen and Yi Wang and has published in prestigious journals such as Kidney International, Small and Journal of the American Society of Nephrology.

In The Last Decade

Yingfeng Shi

44 papers receiving 1.3k citations

Peers

Yingfeng Shi
Haidong Yan China
Jianwei Tian China
Ernesto Martín‐Núñez Spain
Kazutomo Sawai Japan
Maria Teresa Gandolfo Italy
Ruixia Sun China
Zhangzhe Peng China
Zhanmei Zhou China
Akira Mima Japan
Shuguang Yuan China
Haidong Yan China
Yingfeng Shi
Citations per year, relative to Yingfeng Shi Yingfeng Shi (= 1×) peers Haidong Yan

Countries citing papers authored by Yingfeng Shi

Since Specialization
Citations

This map shows the geographic impact of Yingfeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingfeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingfeng Shi more than expected).

Fields of papers citing papers by Yingfeng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingfeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingfeng Shi. The network helps show where Yingfeng Shi may publish in the future.

Co-authorship network of co-authors of Yingfeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yingfeng Shi. A scholar is included among the top collaborators of Yingfeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingfeng Shi. Yingfeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yingfeng, Jinqing Li, Hui Chen, et al.. (2025). Inhibition of Caspase‐1 Suppresses GSDMD‐mediated Peritoneal Mesothelial Cell Pyroptosis and Inflammation in Peritoneal Fibrosis. Small. 21(14). e2409362–e2409362. 2 indexed citations
2.
Chen, Hui, Yingfeng Shi, Jinqing Li, et al.. (2025). Protein Arginine Methyltransferase 1-mediated Histone H4R3 Dimethyl Asymmetric enhances Epidermal Growth Factor Receptor signaling to promote Peritoneal Fibrosis. International Journal of Biological Sciences. 21(9). 4010–4026. 1 indexed citations
3.
4.
5.
Chen, Hui, Yingfeng Shi, Jinqing Li, et al.. (2023). Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization. Frontiers in Immunology. 14. 1137332–1137332. 20 indexed citations
6.
Chen, Hui, Yan Hu, Xiaoyan Ma, et al.. (2023). Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization. Cell Death and Disease. 14(4). 253–253. 49 indexed citations
7.
Chen, Si, Xiaoyan Ma, Xun Zhou, et al.. (2022). An updated clinical prediction model of protein-energy wasting for hemodialysis patients. Frontiers in Nutrition. 9. 933745–933745. 2 indexed citations
8.
Shi, Yingfeng, Min Tao, Hui Chen, et al.. (2022). Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis. Kidney International. 103(3). 544–564. 37 indexed citations
9.
Hu, Yan, Yingfeng Shi, Hui Chen, et al.. (2022). Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. Frontiers in Immunology. 13. 858494–858494. 72 indexed citations
10.
Shi, Yingfeng, Jinqing Li, Hui Chen, et al.. (2022). Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization. Frontiers in Immunology. 13. 899140–899140. 21 indexed citations
11.
Zhou, Xun, Hui Chen, Jinqing Li, et al.. (2022). The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases. Frontiers in Pharmacology. 13. 885527–885527. 8 indexed citations
12.
Tao, Min, Xiaoyan Ma, Yingfeng Shi, et al.. (2021). Prevalence and related factors of hyperuricaemia in Shanghai adult women of different ages: a multicentre and cross-sectional study. BMJ Open. 11(9). e048405–e048405. 4 indexed citations
13.
Zhou, Xun, Hui Chen, Yingfeng Shi, et al.. (2021). The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury. Frontiers in Pharmacology. 12. 695237–695237. 13 indexed citations
14.
Shi, Yingfeng, Yan Hu, Yi Wang, et al.. (2021). Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Frontiers in Pharmacology. 12. 724141–724141. 22 indexed citations
15.
Shi, Yingfeng, Jun Ni, Lunxian Tang, et al.. (2021). Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells. Frontiers in Pharmacology. 12. 722638–722638. 21 indexed citations
16.
Ma, Xiaoyan, Yingfeng Shi, Min Tao, et al.. (2020). Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study. BMJ Open. 10(2). e029949–e029949. 26 indexed citations
17.
18.
Liu, Na, Yingfeng Shi, & Shougang Zhuang. (2016). Autophagy in Chronic Kidney Diseases. Kidney Diseases. 2(1). 37–45. 40 indexed citations
19.
Wang, Li, Liuqing Xu, Yingfeng Shi, et al.. (2015). Establishment of uric acid associated nephropathy animal model and the underlying mechanisms. 31(3). 203–207. 2 indexed citations
20.
Liu, Na, Li Wang, Tao Yang, et al.. (2015). EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy. Journal of the American Society of Nephrology. 26(11). 2716–2729. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haidong Yan Breakdown of academic impact, for papers by Jianwei Tian Breakdown of academic impact, for papers by Ernesto Martín‐Núñez Breakdown of academic impact, for papers by Kazutomo Sawai Breakdown of academic impact, for papers by Maria Teresa Gandolfo Breakdown of academic impact, for papers by Ruixia Sun Breakdown of academic impact, for papers by Zhangzhe Peng Breakdown of academic impact, for papers by Zhanmei Zhou Breakdown of academic impact, for papers by Akira Mima Breakdown of academic impact, for papers by Shuguang Yuan
Rankless by CCL
2026